Literature DB >> 28400098

Olfactory dysfunction in early Parkinson's disease is associated with short latency afferent inhibition reflecting central cholinergic dysfunction.

Eungseok Oh1, Jinse Park2, Jinyoung Youn3, Ji Sun Kim4, Suyeon Park5, Wooyoung Jang6.   

Abstract

OBJECTIVE: Our study aimed to determine whether the short latency afferent inhibition (SAI) response could be associated with the severity of olfactory dysfunction in PD patients.
METHODS: A total of 71 PD patients and 20 controls were enrolled. All PD patients were classified into 3 groups by the severity of the olfactory deficit. Single-pulse transmagnetic stimulation (TMS) parameters and SAI were assessed.
RESULTS: The integrated SAI in the PD with anosmia and PD with hyposomia groups was significantly less inhibited than that in the PD with normosmia and control groups [64.79 {Interquartile range (IQR): 59.96, 71.33}, 84.79 {IQR: 75.03, 90.63} versus 36.72 {IQR: 32.28, 48.33}, 42.15 {IQR: 34.60, 44.96}, respectively]. In PD subjects, the severity of olfactory dysfunction also showed a significant negative correlation with the SAI response (r=-0.829, p<0.001).
CONCLUSIONS: Considering that the SAI response partly reflects central cholinergic dysfunction and that our study shows a relationship between the SAI response and the severity of olfactory dysfunction in PD, our findings indicate that cholinergic dysfunction could possibly contribute to the pathogenesis of olfactory dysfunction in early PD. SIGNIFICANCE: SAI could be a useful marker to detect severe olfactory dysfunction in PD.
Copyright © 2017 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cholinergic system; Korean version of the Sniffin' stick test (KVSS); Olfaction; Parkinson’s disease; Short latency afferent inhibition (SAI)

Mesh:

Year:  2017        PMID: 28400098     DOI: 10.1016/j.clinph.2017.03.011

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  11 in total

Review 1.  Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.

Authors:  Raffaele Nardone; Francesco Brigo; Viviana Versace; Yvonne Höller; Frediano Tezzon; Leopold Saltuari; Eugen Trinka; Luca Sebastianelli
Journal:  J Neural Transm (Vienna)       Date:  2017-08-12       Impact factor: 3.575

Review 2.  The Cholinergic Brain in Parkinson's Disease.

Authors:  Jacopo Pasquini; David J Brooks; Nicola Pavese
Journal:  Mov Disord Clin Pract       Date:  2021-08-23

Review 3.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

Review 4.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

5.  Arterial spin labeling detects perfusion patterns related to motor symptoms in Parkinson's disease.

Authors:  Swati Rane; Natalie Koh; John Oakley; Christina Caso; Cyrus P Zabetian; Brenna Cholerton; Thomas J Montine; Thomas Grabowski
Journal:  Parkinsonism Relat Disord       Date:  2020-05-11       Impact factor: 4.891

Review 6.  Systematic review and meta-analysis of Sniffin Sticks Test performance in Parkinson's disease patients in different countries.

Authors:  Sheila Trentin; Bruno Samuel Fraiman de Oliveira; Yuri Ferreira Felloni Borges; Carlos Roberto de Mello Rieder
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-28       Impact factor: 2.503

Review 7.  Molecular and Genetic Factors Involved in Olfactory and Gustatory Deficits and Associations with Microbiota in Parkinson's Disease.

Authors:  Melania Melis; Antje Haehner; Mariano Mastinu; Thomas Hummel; Iole Tomassini Barbarossa
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

8.  Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson's disease.

Authors:  Ming-Ching Wen; Zheyu Xu; Zhonghao Lu; Ling Ling Chan; Eng King Tan; Louis C S Tan
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

Review 9.  A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders.

Authors:  Sagrario Manzano; Luis Agüera; Miquel Aguilar; Javier Olazarán
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

Review 10.  Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease.

Authors:  Bruce A Chase; Katerina Markopoulou
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.